Cargando…

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281

Detalles Bibliográficos
Autores principales: Dusabimana, Alfred, Siewe Fodjo, Joseph Nelson, Ndahura, Michel Mandro, Mmbando, Bruno P., Jada, Stephen Raimon, Boven, Annelies, De Smet, Eric, Ukety, Tony, Njamnshi, Alfred K., Laudisoit, Anne, Abrams, Steven, Colebunders, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324475/
https://www.ncbi.nlm.nih.gov/pubmed/35890065
http://dx.doi.org/10.3390/pathogens11070746
_version_ 1784756816092069888
author Dusabimana, Alfred
Siewe Fodjo, Joseph Nelson
Ndahura, Michel Mandro
Mmbando, Bruno P.
Jada, Stephen Raimon
Boven, Annelies
De Smet, Eric
Ukety, Tony
Njamnshi, Alfred K.
Laudisoit, Anne
Abrams, Steven
Colebunders, Robert
author_facet Dusabimana, Alfred
Siewe Fodjo, Joseph Nelson
Ndahura, Michel Mandro
Mmbando, Bruno P.
Jada, Stephen Raimon
Boven, Annelies
De Smet, Eric
Ukety, Tony
Njamnshi, Alfred K.
Laudisoit, Anne
Abrams, Steven
Colebunders, Robert
author_sort Dusabimana, Alfred
collection PubMed
description
format Online
Article
Text
id pubmed-9324475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93244752022-07-27 Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281 Dusabimana, Alfred Siewe Fodjo, Joseph Nelson Ndahura, Michel Mandro Mmbando, Bruno P. Jada, Stephen Raimon Boven, Annelies De Smet, Eric Ukety, Tony Njamnshi, Alfred K. Laudisoit, Anne Abrams, Steven Colebunders, Robert Pathogens Correction MDPI 2022-06-30 /pmc/articles/PMC9324475/ /pubmed/35890065 http://dx.doi.org/10.3390/pathogens11070746 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Dusabimana, Alfred
Siewe Fodjo, Joseph Nelson
Ndahura, Michel Mandro
Mmbando, Bruno P.
Jada, Stephen Raimon
Boven, Annelies
De Smet, Eric
Ukety, Tony
Njamnshi, Alfred K.
Laudisoit, Anne
Abrams, Steven
Colebunders, Robert
Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title_full Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title_fullStr Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title_full_unstemmed Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title_short Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
title_sort correction: dusabimana et al. surveillance for onchocerciasis-associated epilepsy and ov16 igg4 testing of children 6–10 years old should be used to identify areas where onchocerciasis elimination programs need strengthening. pathogens 2022, 11, 281
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324475/
https://www.ncbi.nlm.nih.gov/pubmed/35890065
http://dx.doi.org/10.3390/pathogens11070746
work_keys_str_mv AT dusabimanaalfred correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT siewefodjojosephnelson correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT ndahuramichelmandro correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT mmbandobrunop correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT jadastephenraimon correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT bovenannelies correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT desmeteric correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT uketytony correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT njamnshialfredk correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT laudisoitanne correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT abramssteven correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281
AT colebundersrobert correctiondusabimanaetalsurveillanceforonchocerciasisassociatedepilepsyandov16igg4testingofchildren610yearsoldshouldbeusedtoidentifyareaswhereonchocerciasiseliminationprogramsneedstrengtheningpathogens202211281